W

ASHINGTON — One of the first big issues Scott Gottlieb will have to weigh in on if confirmed as Food and Drug commissioner is what to do about the booming field of diagnostic tests.

Gottlieb, a physician and libertarian scholar, has been lukewarm on whether to regulate in vitro clinical tests, a category that includes finished products such as test kits and platforms as well as laboratory developed tests (LDTs), which are lab protocols used for diagnostics.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X